Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Intraventricular antibiotics represent a potential adjunct to intravenous antibiotics in central nervous system infections, to achieve adequate drug concentrations in cerebrospinal fluid. In our single-center experience, describing 37 treatment episodes, intraventricular antibiotics mostly targeting shunt-associated central nervous system infections were generally well tolerated and associated with rapid clearance of cerebrospinal fluid. Large randomized controlled trials are needed to better assess treatment efficacy.

More information Original publication

DOI

10.1097/INF.0000000000005198

Type

Journal article

Publication Date

2026-02-26T00:00:00+00:00

Keywords

external ventricular device, intraventricular antibiotics, ventriculoperitoneal